Executive Vice President, Chief R&D Officer Former Visiting Professor of Biochemistry at Imperial College, London Former Head of the Molecular Sciences Division of Glaxo Wellcome Inc. (present Glaxo Smithkline plc.) Former CEO of Inpharmatica Ltd.(present Galapagos NV) Founder and CEO of Heptares Therapeutics Ltd.
Healthcare